MedTrace Logo

Arabic NODA Validation Study for Autism Diagnosis in Saudi Arabia

NCT07089108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-07-28

No results posted yet for this study

Summary

This study aims to validate the Arabic adaptation of the Naturalistic Observation Diagnostic Assessment (NODA), a telehealth tool designed to help diagnose Autism Spectrum Disorder (ASD) in young children. NODA guides parents to record home videos of their child in specific everyday situations, which are then reviewed remotely by trained clinicians. The study will compare the results from NODA video assessments to gold-standard in-person diagnostic evaluations. By testing the accuracy and feasibility of Arabic NODA in Saudi Arabia, this research may help improve access to early ASD diagnosis, especially for families in remote or underserved areas.

Conditions

  • Autism Spectrum Disorder (ASD)
  • Neurodevelopmental Disorders
  • Child Development Disorders, Pervasive

Interventions

BEHAVIORAL

Arabic NODA Video-Based Diagnostic Assessment

NODA (Naturalistic Observation Diagnostic Assessment) is a telehealth-based diagnostic tool for Autism Spectrum Disorder (ASD) that guides caregivers to record structured home videos of their child's behavior using a smartphone app. In this study, a culturally adapted Arabic version of NODA was used to capture four standardized behavioral scenarios, which were later reviewed by licensed clinicians for diagnostic evaluation.

Sponsors & Collaborators

  • Prince Sultan Military Medical City

    lead OTHER

Eligibility

Min Age
6 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2022-08-21
Completion
2022-12-04

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07089108 on ClinicalTrials.gov